Reslizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study
Clinical trial NCT02947945 · RECRUITING
Trial details
- NCT number
- NCT02947945
- Sponsor
- National Jewish Health
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-12
- Primary completion
- 2018-12-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.